Efficacy of a 4-Week Swallowing Rehabilitation Program Combined With Pyriform Sinus Ballooning in Patients With Post-stroke Dysphagia.
10.5535/arm.2018.42.4.542
- Author:
Yong Kyun KIM
1
;
Kyun Yeon LEE
;
Sang Heon LEE
Author Information
1. Department of Physical Medicine and Rehabilitation, Myongji Hospital, Seonam University College of Medicine, Goyang, Korea. shf3226@naver.com
- Publication Type:Multicenter Study ; Original Article
- Keywords:
Stroke;
Deglutition disorders;
Rehabilitation;
Pharynx;
Larynx
- MeSH:
Deglutition Disorders*;
Deglutition*;
Humans;
Larynx;
Outcome Assessment (Health Care);
Pharynx;
Pyriform Sinus*;
Rehabilitation*;
Stroke
- From:Annals of Rehabilitation Medicine
2018;42(4):542-550
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: To assess the efficacy of a 4-week swallowing rehabilitation program combined with pyriform sinus ballooning in patients with post-stroke dysphagia (PSD). METHODS: We evaluated a total of 30 patients (n=30) with PSD who were admitted to our medical institution between May of 2014 and October of 2016. These patients were randomly assigned to either the trial group (n=15; a 20-minute conventional rehabilitation followed by a 10-minute pyriform sinus ballooning) or the control group (n=15; a 30-minute conventional rehabilitation). In these patients, the efficacy outcome measures were pharyngeal remnant, the pharyngeal transit time, the Penetration Aspiration Scale (PAS) scores and the Videofluoroscopic Dysphagia Scale (VDS) scores. We compared the differences in efficacy outcome measures at 4 weeks from baseline between the two groups. RESULTS: There were significant changes in the pharyngeal remnant, the pharyngeal transit time, the PAS scores and the VDS scores at 4 weeks from baseline between the two groups (p < 0.0001, p=0.0001, p < 0.0001, and p=0.0048, respectively). There were no treatment-emergent adverse events in our series. CONCLUSION: Our 4-week rehabilitation program combined with pyriform sinus ballooning is an effective and safe modality in patients with PSD. However, further large-scale, long-term, and multi-center studies are needed to corroborate our results.
